News

BioStat® Research
& Development Centre

2023 2022 2021 older
ViciData and Biostat project with the support of a Norwegian funds
06
November
2023
ViciData and Biostat project with the support of a Norwegian funds
ViciData and Biostat are developing Digital Twin technology. Their joint project “Digital Twin of the Eye&rdquo...
AI in Medfile: Algorithms Assisting Doctors
27
October
2023
AI in Medfile: Algorithms Assisting Doctors
Artificial intelligence, machine learning. Biostat programmers have created a Drug Assistant function in the Medfile ...
Biostat created VetFile  - software for veterinarians
19
October
2023
Biostat created VetFile - software for veterinarians
Based on our years of experience in developing software for electronic medical records, we have created an applicatio...
Biostat is in its 5th year with R&D center status
10
October
2023
Biostat is in its 5th year with R&D center status
For the fifth consecutive year, the Ministry of Development and Technology has granted Biostat the status of a resear...
Biostat’s courses offer expanding: all about statistics in the CRO
21
July
2023
Biostat’s courses offer expanding: all about statistics in the CRO
The Research and Development Centre Biostat is consistently expanding its online training offer aimed at both candida...
Biostat getting stronger on the European markets
17
April
2023
Biostat getting stronger on the European markets
In recent years, the Biostat Research and Development Center has strengthened its position as a CRO company and a str...
The Forbes Diamonds 2023: Biostat among the TOP 100 most dynamically developing companies.
28
March
2023
The Forbes Diamonds 2023: Biostat among the TOP 100 most dynamically developing companies.
Biostat was featured in the top 100 of the Forbes Diamonds 2023 ranking of the most dynamically developing companies ...
Two Biostat projects feautured on the Innovation Map in healthcare
23
March
2023
Two Biostat projects feautured on the Innovation Map in healthcare
Medfile EDM and eCRF.biz.pl - two innovative projects implemented by Biostat were featured in the "Innovation Ma...
The launch of Medfile on the Norwegian market
01
March
2023
The launch of Medfile on the Norwegian market
The Medfile software is now available on the Norwegian market at medfile.no. The adaptation of the program for this m...
2022 at Biostat. Large growths, new markets, new clients
06
February
2023
2022 at Biostat. Large growths, new markets, new clients
30 new projects and an increase by 70% in the incomes i...
27
October
2023
AI in Medfile: Algorithms Assisting Doctors
27
October
2023

AI in Medfile: Algorithms Assisting Doctors

Artificial intelligence, machine learning. Biostat programmers have created a Drug Assistant function in the Medfile electronic medical documentation software. This is nothing more than a mathematical model based on artificial intelligence. This solution significantly facilitates and supports the work of doctors and medical professionals.

 

The Biostat Research and Development Center has been successfully developing its proprietary electronic medical documentation software, Medfile, for several years. Currently, Medfile is one of the most preferred applications in medical offices and clinics, and the program continuously adds advanced features to make the work of doctors and medical staff more manageable.

 

In October of this year, Medfile users gained access to another tool – the Drug Assistant, a virtual medication assistant. Biostat programmers utilized artificial intelligence to create this function.

 

- The Drug Assistant in Medfile is nothing more than a mathematical model based on artificial intelligence. This virtual assistant supports the doctor in the process of prescribing e-prescriptions. Based on previous behavior, the system suggests other drugs related in some way to the initial selection made by the doctor. For example, if the first drug chosen by the doctor is an antibiotic, a complementary medication may be suggested

- explains Tomasz Kusy, Research Development Manager at Biostat.

 

Tomasz Kusy emphasizes that the algorithm created is not intended to replace the doctor but rather to assist medical professionals in the drug selection process. The described mechanism is only a small fraction of the Drug Assistant's capabilities. In the subsequent stages of this project's development, the system will be able to utilize analysis and information from the ICD-10 classification, the behavior of different doctors in the area of a specific diagnosis, and drug interactions.

 

Biostat's CEO, Rafał Piszczek, highlights that the Drug Assistant tool in Medfile is just one of the projects within the Biostat group that utilize artificial intelligence in medical software.

 

- For many years, it has been known that machine learning and artificial intelligence are the future of healthcare in the broadest sense. That's why we consistently invest in the development of our R&D department and AI-based solutions and software

- says Rafał Piszczek.

 

President Piszczek adds that Biostat is not limited to research and development work in the Polish market. Soon, we will provide information about pilot studies conducted by our team in the Norwegian market in the area of Digital Twin.

 

 

Copyright© 2023 Biostat
Cookies